Creo Medical Group PLC (AIM:CREO)

Creo Medical Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.7	3	13.1	43.53	45.09
Short-Term Investments	-	15.5	-	-	-
Cash & Short-Term Investments	8.7	18.5	13.1	43.53	45.09
Cash Growth	-52.97%	41.22%	-69.91%	-3.45%	-44.36%
Accounts Receivable	1.3	7.8	5	3.88	4.24
Other Receivables	2.4	2.8	5.2	4.88	3.1
Receivables	3.7	10.6	10.2	8.76	7.33
Inventory	2.7	8.1	9.3	8.5	6.81
Prepaid Expenses	0.4	0.7	1.1	0.37	0.23
Other Current Assets	40.9	-	-	-	-
Total Current Assets	56.4	37.9	33.7	61.17	59.47
Property, Plant & Equipment	5.9	9.1	9.7	8.6	3.38
Long-Term Investments	2.1	2.1	2.6	1.73	0.5
Goodwill	-	19.1	19.6	18.56	18.26
Other Intangible Assets	0.3	6.8	7.8	8.33	9.78
Long-Term Deferred Tax Assets	-	1.1	1.5	1.71	0.47
Long-Term Deferred Charges	0.2	0.3	0.2	0.36	0.49
Other Long-Term Assets	0.1	0.2	0.1	0.15	0.11
Total Assets	65	76.6	75.2	100.61	92.46
Accounts Payable	0.9	5.7	4.3	3.54	2.46
Accrued Expenses	2.9	-	4.1	5.18	4.19
Short-Term Debt	-	2	3.8	3.32	3.34
Current Portion of Long-Term Debt	2.2	0.5	1.2	1.39	1.85
Current Portion of Leases	0.2	0.6	0.6	0.67	0.62
Current Unearned Revenue	0.1	-	-	-	-
Other Current Liabilities	14.2	1.1	3.4	5.63	5.56
Total Current Liabilities	20.5	9.9	17.4	19.74	18.03
Long-Term Debt	1.9	4.4	4.9	3.79	5.16
Long-Term Leases	0.1	0.8	1.2	1.39	1.39
Long-Term Deferred Tax Liabilities	-	1.4	2	1.79	2
Other Long-Term Liabilities	0.1	0.3	0.4	0.59	3.09
Total Liabilities	22.6	16.8	25.9	27.29	29.66
Common Stock	0.4	0.4	0.2	0.18	0.16
Additional Paid-In Capital	192	180.9	149.5	149.45	115.26
Retained Earnings	-173.1	-144.4	-122.7	-95.76	-71.17
Comprehensive Income & Other	23.1	22.9	22.3	19.45	18.55
Total Common Equity	42.4	59.8	49.3	73.32	62.81
Shareholders' Equity	42.4	59.8	49.3	73.32	62.81
Total Liabilities & Equity	65	76.6	75.2	100.61	92.46
Total Debt	4.4	8.3	11.7	10.56	12.36
Net Cash (Debt)	4.3	10.2	1.4	32.98	32.74
Net Cash Growth	-57.84%	628.57%	-95.75%	0.74%	-59.25%
Net Cash Per Share	0.01	0.03	0.01	0.20	0.21
Filing Date Shares Outstanding	402.15	351.25	181.38	178.1	157.89
Total Common Shares Outstanding	402.15	351.25	181.38	178.1	157.89
Working Capital	35.9	28	16.3	41.43	41.44
Book Value Per Share	0.11	0.17	0.27	0.41	0.40
Tangible Book Value	42.1	33.9	21.9	46.42	34.77
Tangible Book Value Per Share	0.10	0.10	0.12	0.26	0.22
Land	4.6	4.6	4.6	4.51	-
Machinery	4.3	6.8	6	5.11	3.78
Construction In Progress	0.1	0.1	1.4	0.15	0.03
Leasehold Improvements	2.3	2.6	0.9	0.74	0.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.